Revolution Medicines, Inc.
POLYCYCLIC COMPOUNDS AS ALLOSTERIC SHP2 INHIBITORS
Last updated:
Abstract:
The present disclosure is directed to inhibitors of SHP2 and their use in the treatment of disease. Also disclosed are pharmaceutical compositions comprising the same.
Status:
Application
Type:
Utility
Filling date:
11 Jun 2020
Issue date:
31 Dec 2020